197 related articles for article (PubMed ID: 8247537)
21. Smallest region of overlapping deletion in 1p36 in human neuroblastoma: a 1 Mbp cosmid and PAC contig.
Bauer A; Savelyeva L; Claas A; Praml C; Berthold F; Schwab M
Genes Chromosomes Cancer; 2001 Jul; 31(3):228-39. PubMed ID: 11391793
[TBL] [Abstract][Full Text] [Related]
22. [The neuroblastoma, "enfant terrible" among pediatric tumors].
Laureys G
Verh K Acad Geneeskd Belg; 2003; 65(1):5-23; discussion 23-8. PubMed ID: 12802894
[TBL] [Abstract][Full Text] [Related]
23. A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3.
White PS; Maris JM; Beltinger C; Sulman E; Marshall HN; Fujimori M; Kaufman BA; Biegel JA; Allen C; Hilliard C; Valentine MB; Look AT; Enomoto H; Sakiyama S; Brodeur GM
Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5520-4. PubMed ID: 7777541
[TBL] [Abstract][Full Text] [Related]
24. Monosomy 1p36.31-33-->pter due to a paternal reciprocal translocation: prognostic significance of FISH analysis.
Blennow E; Bui TH; Wallin A; Kogner P
Am J Med Genet; 1996 Oct; 65(1):60-7. PubMed ID: 8914743
[TBL] [Abstract][Full Text] [Related]
25. Peculiar allelotype associated with susceptibility to neuroblastoma.
Perri P; Pession A; Mazzocco K; Strigini P; Iolascon A; Basso G; Tonini GP
Genes Chromosomes Cancer; 1996 Sep; 17(1):60-3. PubMed ID: 8889508
[TBL] [Abstract][Full Text] [Related]
26. Homozygous deletion in a neuroblastoma cell line defined by a high-density STS map spanning human chromosome band 1p36.
Chen YZ; Soeda E; Yang HW; Takita J; Chai L; Horii A; Inazawa J; Ohki M; Hayashi Y
Genes Chromosomes Cancer; 2001 Aug; 31(4):326-32. PubMed ID: 11433523
[TBL] [Abstract][Full Text] [Related]
27. Loss of heterozygosity for alleles on chromosomes 11q and 14q in neuroblastoma.
Srivatsan ES; Murali V; Seeger RC
Prog Clin Biol Res; 1991; 366():91-8. PubMed ID: 2068183
[TBL] [Abstract][Full Text] [Related]
28. Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification.
Cheng NC; Van Roy N; Chan A; Beitsma M; Westerveld A; Speleman F; Versteeg R
Oncogene; 1995 Jan; 10(2):291-7. PubMed ID: 7838528
[TBL] [Abstract][Full Text] [Related]
29. Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma.
Thompson PM; Maris JM; Hogarty MD; Seeger RC; Reynolds CP; Brodeur GM; White PS
Cancer Res; 2001 Jan; 61(2):679-86. PubMed ID: 11212268
[TBL] [Abstract][Full Text] [Related]
30. Molecular analysis of the putative tumour-suppressor gene EXTL1 in neuroblastoma patients and cell lines.
Mathysen D; Van Roy N; Van Hul W; Laureys G; Ambros P; Speleman F; Wuyts W
Eur J Cancer; 2004 May; 40(8):1255-61. PubMed ID: 15110891
[TBL] [Abstract][Full Text] [Related]
31. Familial predisposition to neuroblastoma does not map to chromosome band 1p36.
Maris JM; Kyemba SM; Rebbeck TR; White PS; Sulman EP; Jensen SJ; Allen C; Biegel JA; Yanofsky RA; Feldman GL; Brodeur GM
Cancer Res; 1996 Aug; 56(15):3421-5. PubMed ID: 8758905
[TBL] [Abstract][Full Text] [Related]
32. A cluster of genes located in 1p36 are down-regulated in neuroblastomas with poor prognosis, but not due to CpG island methylation.
Carén H; Ejeskär K; Fransson S; Hesson L; Latif F; Sjöberg RM; Krona C; Martinsson T
Mol Cancer; 2005 Mar; 4(1):10. PubMed ID: 15740626
[TBL] [Abstract][Full Text] [Related]
33. Recurrent 1;17 translocations in human neuroblastoma reveal nonhomologous mitotic recombination during the S/G2 phase as a novel mechanism for loss of heterozygosity.
Caron H; van Sluis P; van Roy N; de Kraker J; Speleman F; Voûte PA; Westerveld A; Slater R; Versteeg R
Am J Hum Genet; 1994 Aug; 55(2):341-7. PubMed ID: 8037211
[TBL] [Abstract][Full Text] [Related]
34. Alterations in the PITSLRE protein kinase gene complex on chromosome 1p36 in childhood neuroblastoma.
Lahti JM; Valentine M; Xiang J; Jones B; Amann J; Grenet J; Richmond G; Look AT; Kidd VJ
Nat Genet; 1994 Jul; 7(3):370-5. PubMed ID: 7920654
[TBL] [Abstract][Full Text] [Related]
35. Clinical investigation of neuroblastoma with partial deletion in the short arm of chromosome 1.
Ohtsu K; Hiyama E; Ichikawa T; Matsuura Y; Yokoyama T
Clin Cancer Res; 1997 Jul; 3(7):1221-8. PubMed ID: 9815803
[TBL] [Abstract][Full Text] [Related]
36. Genetic alterations involving chromosome 1p in children with neuroblastoma.
Avigad S; Tamir Y; Yaniv I; Goshen J; Kaplinsky C; Cohen IJ; Zaizov R
Isr J Med Sci; 1994 Aug; 30(8):639-41. PubMed ID: 7913920
[TBL] [Abstract][Full Text] [Related]
37. Comparative genomic hybridization study of primary neuroblastoma tumors. United Kingdom Children's Cancer Study Group.
Lastowska M; Nacheva E; McGuckin A; Curtis A; Grace C; Pearson A; Bown N
Genes Chromosomes Cancer; 1997 Mar; 18(3):162-9. PubMed ID: 9071568
[TBL] [Abstract][Full Text] [Related]
38. Chromosome 1p allelic loss in neuroblastoma: prognosis, genomic imprinting and 1;17 translocations.
Caron H; van Sluis P; van Roy N; Beks L; Maes P; Pereira do Tanque R; Slater R; de Kraker J; Speleman F; Voûte PA
Prog Clin Biol Res; 1994; 385():35-42. PubMed ID: 7972230
[No Abstract] [Full Text] [Related]
39. Stepwise occurrence of a complex unbalanced translocation in neuroblastoma leading to insertion of a telomere sequence and late chromosome 17q gain.
Schleiermacher G; Bourdeaut F; Combaret V; Picrron G; Raynal V; Aurias A; Ribeiro A; Janoueix-Lerosey I; Delattre O
Oncogene; 2005 May; 24(20):3377-84. PubMed ID: 15735707
[TBL] [Abstract][Full Text] [Related]
40. Characterisation of the chromosome breakpoints in a patient with a constitutional translocation t(1;17)(p36.31-p36.13;q11.2-q12) and neuroblastoma.
Laureys G; Versteeg R; Speleman F; van der Drift P; Francke U; Opdenakker G; Van Roy N
Eur J Cancer; 1995; 31A(4):523-6. PubMed ID: 7576958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
